SavedAdd your journal

Journals / Molecular Oncologic Imaging / 2026 / Volume: 2 Issue: 1

F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up

Zehra Pınar Koç(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, NÜKLEER TIP ANABİLİM DALI)0000-0002-3274-5790
Pınar Pelin Özcan(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, NÜKLEER TIP ANABİLİM DALI)0000-0003-0147-2678
Emel Sezer(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, İÇ HASTALIKLARI ANABİLİM DALI, TIBBİ ONKOLOJİ BİLİM DALI)0000-0001-9881-3533
Gökçe Yavan(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, NÜKLEER TIP ANABİLİM DALI)0000-0002-7332-6293
Pages
—
Publication Date
2022-04-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Previous reports have determined the F-18 FDG PET/CT findings of this tumor (1) and this is the first case with follow up results in the literature as far as we know.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ameloblastoma is a benign odontogenic tumor that originate from dental region (1).
📊
Key Findings & Data:Ameloblastoma is a benign odontogenic tumor that originate from dental region (1).
💡
Conclusion & Impact:Previous reports have determined the F-18 FDG PET/CT findings of this tumor (1) and this is the first case with follow up results in the literature as far as we know.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:Ameloblastoma · FDG PET/CT · Treatment Responce

Abstract

Ameloblastoma is a benign odontogenic tumor that originate from dental region (1). Previous reports have determined the F-18 FDG PET/CT findings of this tumor (1) and this is the first case with follow up results in the literature as far as we know.

🔖

Cite This Article

Koç, Z. P., Özcan, P. P., Sezer, E., Yavan, G. (2022). F-18 FDG PET/CT imaging in the Ameloblastoma Follow Up. Molecular Oncologic Imaging, Volume: 2 Issue: 1. https://ajindex.com/articles/1626562

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Seno S, Kitajima K, Inokuchi G, Nibu K, Itoh T, Ejima Y, Sasaki R, Sugimoto K, Sugimura K. FDG-PET findings of Ameloblastoma: a case report. Springerplus. 2015;4:250.
  2. Inoue N, Shimojyo M, Iwai H, Ohtsuki H, Yasumizu R, Shintaku M, Taniguchi N, Inada M, Arika T, Morita S, et al. Malignant ameloblastoma with pulmonary metastasis and hypercalcemia. Report of an autopsy case and review of the literature. Am J Clin Pathol. 1988;90(4):474-81
  3. Devenney-Cakir B, Dunfee B, Subramaniam R, Sundararajan D, Mehra P, Spiegel J, Sakai O. Ameloblastic carcinoma of the mandible with metastasis to the skull and lung: advanced imaging appearance including computed tomography, magnetic resonance imaging and positron emission tomography computed tomography. Dentomaxillofac Radiol. 2010;39(7):449-53Iban, M. C. (2020). Geospatial data science response to COVID-19 crisis and pandemic isolation tracking. Turkish Journal of Geosciences, 1(1), 1-7.
  4. Nguyen BD. Malignant ameloblastoma with thoracic vertebral metastasis: PET/CT and MR imaging. Clin Nucl Med. 2005 Jun;30(6):450-2Yakar, M., Yılmaz, H. M., & Mutluoglu, O. (2014). Performance of photogrammetric and terrestrial laser scanning methods in volume computing of excavation and filling areas. Arabian Journal for Science and Engineering, 39, 387-394.
  5. Otsuru M, Aoki T, Tsukinoki K, Ota Y, Karakida K, Yamazaki H, Yasuda M, Kaneko A. Usefulness of 18F-fluorodeoxyglucose positron emission tomography for detecting ameloblastoma, with special reference to glucose transporter-1 expression. J Oral Maxillofac Surg. 2008 Aug;66(8):1761-5.